Maria Cristina De Vera Mudry

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines

Christian Klein, Inja Waldhauer, Valeria Nicolini et al. · OncoImmunology · 2017 · 271 citations · Full text

Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation

Juliana Bessa, Claas A. Meyer, Maria Cristina De Vera Mudry et al. · Journal of Autoimmunity · 2014 · 162 citations

Inflammation, Cytokine, Autoimmune Disease +9

Biomarker Discovery by Imaging Mass Spectrometry

Hélène Meistermann, Jeremy L. Norris, Hans R. Aerni et al. · Molecular & Cellular Proteomics · 2006 · 144 citations · Full text

Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2)

Katrijn Bogman, Dietmar Schwab, Marie‐Laure Delporte et al. · Hypertension · 2016 · 97 citations · Full text

Deep Learning in Toxicologic Pathology: A New Approach to Evaluate Rodent Retinal Atrophy

Maria Cristina De Vera Mudry, Jim Martin, Vanessa Schumacher et al. · Toxicologic Pathology · 2020 · 10 citations

Ocular Disease, Engineering, Pathology +16